No. 23-9

AstraZeneca UK Limited, et al. v. Joshua Atchley, et al.

Lower Court: District of Columbia
Docketed: 2023-07-05
Status: GVR
Type: Paid
CVSGAmici (2)Relisted (2) Experienced Counsel
Tags: aiding-and-abetting anti-terrorism-act direct-liability foreign-government-agency foreign-terrorist-organization proximate-causation specific-attack terrorist-organization transacting-with-government-agency
Latest Conference: 2024-06-20 (distributed 2 times)
Question Presented (from Petition)

1. Whether, in light of Taamneh, the Court should grant, vacate, and remand for further proceedings.

2. Whether plaintiffs plead proximate causation as required for ATA direct liability by alleging that defendants transacted with a foreign-government agency that was in turn infiltrated by the group that injured plaintiffs.

3. Whether a U.S.-designated foreign terrorist organization "plan[s]" or "authorize[s]" a specific attack—as required for ATA aiding-and-abetting liability—by providing general support or inspiration to a different group that carries out the attack.

Question Presented (AI Summary)

Whether ATA aiding-and-abetting liability requires conscious-voluntary-culpable-participation

Docket Entries

2024-07-26
Judgment Issued.
2024-06-24
Petition GRANTED. Judgment VACATED and case REMANDED for further consideration in light of Twitter, Inc. v. Taamneh, 598 U. S. 471 (2023). Justice Alito took no part in the consideration or decision of this petition.
2024-06-04
DISTRIBUTED for Conference of 6/20/2024.
2024-06-04
Supplemental brief of petitioners AstraZeneca UK Limited, et al. filed. (Distributed)
2024-05-21
Brief amicus curiae of United States filed.
2023-10-02
The Solicitor General is invited to file a brief in this case expressing the views of the United States. Justice Alito took no part in the consideration of this petition.
2023-09-06
DISTRIBUTED for Conference of 9/26/2023.
2023-09-06
Reply of petitioners AstraZeneca UK Limited, et al. filed. (Distributed)
2023-08-23
2023-08-04
Brief amici curiae of Chamber of Commerce of the United States of America, et al. filed.
2023-07-26
Motion to extend the time to file a response is granted and the time is extended to and including August 23, 2023.
2023-07-25
Motion to extend the time to file a response from August 4, 2023 to August 23, 2023, submitted to The Clerk.
2023-06-30
Petition for a writ of certiorari filed. (Response due August 4, 2023)
2023-04-06
Application (22A868) granted by The Chief Justice extending the time to file until July 2, 2023.
2023-04-03
Application (22A868) to extend the time to file a petition for a writ of certiorari from May 4, 2023 to July 3, 2023, submitted to The Chief Justice.

Attorneys

AstraZeneca UK Limited, et al.
Lisa S. BlattWilliams & Connolly LLP, Petitioner
Chamber of Commerce of the United States of America and Pharmaceutical Research and Manufacturers of America
Andrew John PincusMayer Brown LLP, Amicus
Joshua Atchley, et al.
Joshua Daniel BransonKellogg, Hansen, Todd, Figel & Frederick, P.L.L.C., Respondent
United States
Elizabeth B. PrelogarSolicitor General, Amicus